NasdaqGS:MMSIMedical Equipment
Did Positive WAVE Trial Results and Global Approvals Just Shift Merit Medical Systems' (MMSI) Investment Narrative?
In early November 2025, Merit Medical Systems announced positive 24-month clinical results from the WAVE trial for its WRAPSODY Cell-Impermeable Endoprosthesis, with findings presented at major vascular conferences and demonstrating superior performance compared to standard treatments for restoring functional vascular access in hemodialysis patients.
The announcement highlights both the extensive clinical validation and broad regulatory approvals for WRAPSODY CIE, which is now available...